子宫腺肌症对子宫内膜异位症女性妊娠及围产期结局的影响
本研究回顾性分析3年内前瞻性收集的206例子宫内膜异位症孕妇,其中148例(71.8%)仅为子宫内膜异位症,38例(18.4%)为局灶性子宫腺肌症,20例(9.7%)为弥漫性子宫腺肌症。弥漫性子宫腺肌症组较单纯子宫内膜异位症组妊娠相关血浆蛋白A显著降低(0.61 vs 0.88 中位数倍数,P < 0.001),早孕期子宫动脉搏动指数显著升高(2.23 vs 1.67,P < 0.001),中孕期亦显著升高(1.30 vs 0.94,P < 0.001),小于胎龄儿发生率显著升高(40% vs 10.8%,P < 0.001)。局灶性子宫腺肌症组与单纯子宫内膜异位症组无统计学显著差异。Logistic回归分析显示弥漫性子宫腺肌症是小于胎龄儿的唯一独立危险因素(比值比 = 3.744;95% CI,1.158-12.099;P = 0.027)。结论认为子宫内膜异位症孕妇合并弥漫性子宫腺肌症与分娩小于胎龄儿强烈相关,此类孕妇应被视为胎盘功能障碍高危人群,可能需要更密切监测。
要点
- 弥漫性子宫腺肌症组小于胎龄儿发生率为40%,显著高于单纯子宫内膜异位症组的10.8%(P < 0.001)。
- 弥漫性子宫腺肌症是小于胎龄儿的唯一独立危险因素(比值比 = 3.744;95% CI,1.158-12.099;P = 0.027)。
- 局灶性子宫腺肌症组与单纯子宫内膜异位症组在妊娠及围产期结局上无统计学显著差异。
核心结论
- 子宫内膜异位症孕妇合并弥漫性子宫腺肌症与分娩小于胎龄儿强烈相关。
- 弥漫性子宫腺肌症孕妇应被视为胎盘功能障碍高危人群,这些妊娠可能需要更密切监测。
研究设计与样本
- 回顾性分析3年期间前瞻性收集的数据,纳入206例子宫内膜异位症孕妇。
- 148例(71.8%)仅为子宫内膜异位症,38例(18.4%)为局灶性子宫腺肌症,20例(9.7%)为弥漫性子宫腺肌症。
- 子宫腺肌症通过超声诊断并分类为局灶性或弥漫性,纳入自然受孕或辅助生殖技术受孕的患者。
主要发现
- 三组人口学特征(年龄、体重指数、受孕方式)相似。
- 弥漫性子宫腺肌症组较单纯子宫内膜异位症组妊娠相关血浆蛋白A显著降低(0.61 vs 0.88 中位数倍数,P < 0.001)。
- 弥漫性子宫腺肌症组较单纯子宫内膜异位症组早孕期子宫动脉搏动指数显著升高(2.23 vs 1.67,P < 0.001),中孕期亦显著升高(1.30 vs 0.94,P < 0.001)。
- 弥漫性子宫腺肌症组小于胎龄儿发生率显著高于单纯子宫内膜异位症组(40% vs 10.8%,P < 0.001)。
- 局灶性子宫腺肌症组与单纯子宫内膜异位症组无统计学显著差异。
关键数值与推荐
- Logistic回归分析显示弥漫性子宫腺肌症是小于胎龄儿的唯一独立危险因素(比值比 = 3.744;95% CI,1.158-12.099;P = 0.027)。
临床怎么用
- 作者认为,子宫内膜异位症孕妇合并弥漫性子宫腺肌症应被视为胎盘功能障碍高危人群,这些妊娠可能需要更密切监测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Several studies have investigated the correlation between endometriosis and adverse pregnancy and perinatal outcomes. However, the role of adenomyosis as a risk factor for adverse perinatal outcome in women with endometriosis has yet to be established. The aim of this study was to explore if fetal and maternal outcomes, in particular the incidence of a small-for-gestational-age (SGA) infant, are different in pregnant women with endometriosis only from in those with the concomitant presence of diffuse or focal adenomyosis. METHODS: This was a retrospective analysis of data collected prospectively during a 3-year period. We included 206 pregnant women with endometriosis: 148 (71.8%) with endometriosis only, 38 (18.4%) with focal adenomyosis and 20 (9.7%) with diffuse adenomyosis. Adenomyosis was diagnosed using ultrasonography and was classified as focal or diffuse. The study included patients who conceived spontaneously or by an assisted reproductive technique. Demographics, ultrasound variables and outcome were compared between women with endometriosis only and those with diffuse and those with focal adenomyosis. Logistic regression analysis was performed to assess the association of variables with SGA at birth in women with diffuse and those with focal adenomyosis. RESULTS: The three groups were similar in demographic characteristics (age, body mass index, mode of conception). Patients with diffuse adenomyosis compared with those with endometriosis only had significantly lower pregnancy-associated plasma protein A (0.61 vs 0.88 multiple of the median, P < 0.001), higher mean uterine artery pulsatility index in the first (2.23 vs 1.67, P < 0.001) and second (1.30 vs 0.94, P < 0.001) trimesters of pregnancy, and higher incidence of SGA (40% vs 10.8%, P < 0.001). No statistically significant differences were found in patients with focal adenomyosis compared with those with endometriosis only. Logistic regression analysis demonstrated that diffuse adenomyosis (odds ratio = 3.744; 95% CI, 1.158-12.099; P = 0.027) was the only independent risk factor for SGA. CONCLUSIONS: The presence of diffuse adenomyosis in pregnant women with endometriosis is strongly associated with delivery of a SGA infant. Women with diffuse adenomyosis should be treated as being at high risk of placental dysfunction, and these pregnancies might therefore need closer monitoring. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Scala C, Leone Roberti Maggiore U, Racca A, et al. Influence of adenomyosis on pregnancy and perinatal outcomes in women with endometriosis. Ultrasound Obstet Gynecol. 2018. PMID: 29266553. doi:10.1002/uog.18989
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。